These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3299425)
1. Commonly used chemotherapeutic agents. Carter BL Prim Care; 1987 Jun; 14(2):293-315. PubMed ID: 3299425 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
5. Safer cancer chemotherapy using a kinetically based experimental approach. Price LA; Hill BT Mt Sinai J Med; 1985 Jun; 52(6):452-9. PubMed ID: 3875025 [No Abstract] [Full Text] [Related]
6. [Prevention of side reactions--present status and problems--special references]. Furue H Gan To Kagaku Ryoho; 2002 Jul; 29(7):1325-30. PubMed ID: 12146019 [TBL] [Abstract][Full Text] [Related]
7. Nail toxicity induced by cancer chemotherapy. Gilbar P; Hain A; Peereboom VM J Oncol Pharm Pract; 2009 Sep; 15(3):143-55. PubMed ID: 19171552 [TBL] [Abstract][Full Text] [Related]
8. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities]. du Bois A; Lück HJ; Meerpohl HG Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970 [TBL] [Abstract][Full Text] [Related]
9. Metastatic breast cancer: understanding current management options. McGinn K; Moore J Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic chemotherapy for advanced renal cell carcinoma. Yagoda A; Petrylak D; Thompson S Urol Clin North Am; 1993 May; 20(2):303-21. PubMed ID: 8493752 [TBL] [Abstract][Full Text] [Related]
11. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance. Orr JW; Orr P; Kern DH Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175 [TBL] [Abstract][Full Text] [Related]
12. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol. Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387 [TBL] [Abstract][Full Text] [Related]
13. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Shah MA; Schwartz GK Clin Cancer Res; 2001 Aug; 7(8):2168-81. PubMed ID: 11489790 [TBL] [Abstract][Full Text] [Related]
14. [Progress in adjuvant and palliative chemotherapy of colorectal cancer: current status and perspectives]. Scheithauer W Wien Klin Wochenschr; 1993; 105(20):568-79. PubMed ID: 7505075 [TBL] [Abstract][Full Text] [Related]
15. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
16. Review: potential role of cell cycle synchronizing agents in combination treatment modalities of malignant tumors. Zalatnai A In Vivo; 2005; 19(1):85-91. PubMed ID: 15796159 [TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
19. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121 [TBL] [Abstract][Full Text] [Related]